Financial Assistance | FARYDAK® (panobinostat) capsules
Menu Button
FARYDAK (panobinostat) capsules 10mg/15mg/20mg

Important Safety Information, Including Boxed WARNING

What is the most important safety information to know about FARYDAK? FARYDAK can cause serious diarrhea and heart problems

Black box warning

FARYDAK® (PANOBINOSTAT) CAPSULES IS PART OF A COMPREHENSIVE CO-PAY SUPPORT PROGRAM OFFERED BY NOVARTIS ONCOLOGY

Universal Copay Card Universal Copay Card

WITH FARYDAK, WE’RE COMMITTED TO SUPPORTING YOU BY OFFERING CO-PAY ASSISTANCE

You may be eligible for immediate co-pay savings on your next prescription:

  • Commercially insured patients pay no more than $25 per month
  • Annual maximum of $15,000 per calendar year

To find out if you are eligible to save on your next prescription, or to activate your card, call 877-577-7756 or visit us on www.copay.novartisoncology.com

Limitations apply. See program terms and conditions. This offer is not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice.

Terms and Conditions: Valid only for those with commercial insurance. Offer not valid under Medicare, Medicaid, or any other federal or state program. Offer not valid for cash-paying patients, where product is not covered by patient’s commercial insurance, or where plan reimburses you for entire cost of your prescription drug. Offer is not valid where prohibited by law. Valid only in the United States and Puerto Rico. This program is not health insurance. Offer may not be combined with any other rebate, coupon, or offer. This card is the property of Novartis Pharmaceuticals Corporation and must be returned upon request. Novartis reserves the right to rescind, revoke, or amend the program without notice. Patient certifies responsibility for complying with applicable limitations, if any, of any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. This offer expires on December 31, 2017.

Patient Instructions: Present this offer and your insurance card along with a valid prescription at any participating pharmacy or through mail order. Patients with commercial insurance are responsible for up to $25 per 30-day supply and Novartis pays up to $15,000 per calendar year. If patient reaches the maximum annual cap per year of $15,000, patient will be responsible for the difference. Offer expires December 31, 2017. Patient questions should be directed to: 877-577-7756.

When you use this offer, you are certifying that you understand the program rules, regulations, and terms and conditions, and that you will disclose and report the use of this offer as may be required by your insurer. You are not eligible if prescriptions are paid by any federal or state program, or where prohibited by law; and you will otherwise comply with the terms and conditions above.

Pharmacist: When you use this offer, you are certifying that you have not submitted and will not submit a claim for reimbursement under any federal, state, or other governmental programs for this prescription. Pharmacist will comply with his/her obligations when processing the prescription for payment. By using this card, you agree to the terms and conditions of this program.

Pharmacist Instructions for a Patient With an Eligible Third Party: Submit claim to the primary Third-Party Payer first, then submit the balance due to Therapy First Plus as a Secondary Payer COB [coordination of benefits] with patient responsibility amount with a valid Other Coverage Code (eg, 8). The patient is responsible for up to $25 per 30-day supply, with savings up to $15,000 per calendar year, and reimbursement will be received from Therapy First Plus.

Valid Other Coverage Code required. For any questions regarding Therapy First Plus online processing, please call the Help Desk at 1-800-422-5604.

When you use this card, you are certifying that you have not submitted and will not submit a claim for reimbursement under any federal, state, or other governmental programs for this prescription. Pharmacist will comply with his/her obligations when processing the prescription for payment. By using this card, you agree to the terms and conditions of this program. Co-pay cards must be accompanied by a prescription.

ASSISTANCE IS ALSO AVAILABLE IF YOU ARE UNINSURED, UNDERINSURED, OR PAY CASH

Novartis Oncology is committed to helping patients who are living with cancer receive the medicines they need. Patient Assistance Now Oncology (PANO) offers quick and easy access to information about our wide range of resources.

You can get information about our PANO support programs in 2 ways:

  • Call 1-800-282-7630 to speak with a member of our knowledgeable staff dedicated to making access to therapy as simple and convenient as possible; or
  • Visit our website at: www.oncologyaccessnow.com/patient

INDICATION AND IMPORTANT SAFETY INFORMATION

What is FARYDAK® (panobinostat) capsules?

FARYDAK is a prescription medicine used, in combination with bortezomib and dexamethasone, to treat adults with a type of cancer called multiple myeloma after at least 2 other types of treatment have been tried.

It is not known if FARYDAK is safe and effective in children.

IMPORTANT SAFETY INFORMATION

What you should know about FARYDAK

FARYDAK can cause serious side effects.

  • Diarrhea is common with FARYDAK, and can be severe. Tell your doctor right away if you have stomach cramps, loose stools, diarrhea, or if you feel like you are becoming dehydrated. Taking or using stool softeners or laxative medicines may worsen diarrhea; talk to your doctor before taking or using these medicines. Your doctor will regularly check the levels of fluid and electrolytes in your blood during treatment
  • FARYDAK can cause severe heart problems, which can lead to death. Your risk of heart problems may be increased if you have a condition called "long QT syndrome," or other heart problems. Call your doctor and get emergency medical help right away if you experience chest pain, faster or slower heartbeat, heart racing, lightheadedness or feeling faint, dizziness, have blue lips, shortness of breath, or swelling in your legs
  • FARYDAK can cause severe bleeding, which can lead to death. It may take you longer than usual to stop bleeding. Tell your doctor right away if you get any of the following signs of bleeding:
    • blood in your stools or black stools that look like tar
    • pink or brown urine
    • unexpected bleeding, or bleeding that is severe or that you cannot control
    • vomit blood or vomit looks like coffee grounds
    • cough up blood or blood clots
    • increased bruising
    • feeling dizzy or weak
    • confusion
    • change in your speech
    • headache that lasts a long time

Before you take FARYDAK, tell your doctor about all your medical conditions, including if you

  • have diarrhea, heart problems, a history of bleeding problems, an infection, or liver problems. You should not take FARYDAK if you have an infection
  • are pregnant or plan to become pregnant. FARYDAK can harm your unborn baby. You should not become pregnant during treatment with FARYDAK
  • are breastfeeding or plan to breastfeed. It is not known if FARYDAK will pass into your breast milk. You and your health care provider should decide if you will take FARYDAK or breastfeed. You should not do both
  • Females who are able to become pregnant should use effective birth control during treatment with FARYDAK, and for at least 3 months after the last dose of FARYDAK. Males who are sexually active should use a condom during treatment with FARYDAK, and for at least 6 months after the last dose of FARYDAK

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

How to take FARYDAK

  • Take FARYDAK exactly as your doctor tells you, including how much FARYDAK to take and when to take it
  • Your doctor may change your dose, or stop treatment temporarily, if you have side effects. Do not change your dose, or stop taking FARYDAK, without first talking with your doctor
  • Take FARYDAK once on each scheduled day at about the same time
  • FARYDAK can be taken with or without food, and should be swallowed whole with a cup of water. Do not open, crush, or chew FARYDAK
  • If you miss a dose of FARYDAK, take it as soon as possible up to 12 hours after your scheduled dose
  • If you vomit after taking FARYDAK, do not take another capsule. Stay on your schedule, and take your next dose as usual
  • If you take too much FARYDAK, call your doctor
  • Avoid eating star fruit, pomegranate or pomegranate juice, and grapefruit or grapefruit juice, while taking FARYDAK. These foods may affect the amount of FARYDAK in your blood

FARYDAK may cause serious side effects.

  • See "What you should know about FARYDAK"
  • Low blood cell counts are common with FARYDAK, and can be severe. Your doctor will check your blood counts before you start FARYDAK, and during your treatment with FARYDAK
    • Low platelet count (thrombocytopenia) can cause unusual bleeding or bruising under your skin
    • Low white cell count (neutropenia) can cause you to get infections
    • Low red blood cell count (anemia) may make you feel weak, tired, or you may get tired easily, you look pale, or you feel short of breath
  • Infection risk is increased while taking FARYDAK. Contact your doctor right away if you have a fever or have any signs of an infection including sweats or chills, cough, flu-like symptoms, shortness of breath, blood in your phlegm, sores on your body, warm or painful areas on your body, or are feeling very tired
  • Your doctor should do blood tests to check your liver before you start taking FARYDAK, and if you have symptoms of liver problems while taking FARYDAK. Call your doctor right away if you feel tired or weak, lose your appetite, have dark urine, upper stomach pain, or yellowing of your skin or the white of your eyes

The most common side effects of FARYDAK include tiredness, nausea, swelling in your arms or legs, decreased appetite, fever, and vomiting. Tell your doctor if you have any side effect that bothers you or does not go away. These are not all the possible side effects of FARYDAK. For more information, ask your doctor or pharmacist. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Boxed WARNING and Medication Guide, for FARYDAK® (panobinostat) capsules.

What is FARYDAK® (panobinostat) capsules?

FARYDAK is a prescription medicine used, in combination with bortezomib and dexamethasone, to treat adults with a type of cancer called multiple myeloma after at least 2 other types of treatment have been tried.

It is not known if FARYDAK is safe and effective in children.

IMPORTANT SAFETY INFORMATION

What you should know about FARYDAK

FARYDAK can cause serious side effects.

  • Diarrhea is common with FARYDAK, and can be severe. Tell your doctor right away if you have stomach cramps, loose stools, diarrhea, or if you feel like you are becoming dehydrated. Taking or using stool softeners or laxative medicines may worsen diarrhea;

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.